Bulletin
Investor Alert

New York Markets Close in:

Market Snapshot Winners and Losers

Regeneron Pharmaceuticals Inc.

NAS: REGN

GO

Set Alerts

Market Index

Overview Profile Charts Financials Historical Quotes Analyst Estimates Options SEC Filings Insiders
/marketstate/country/us
Regeneron Pharmaceuticals Inc.

Countdown to close

REGN
/zigman2/quotes/203149337/composite

$

657.86

Change

+0.71 +0.11%

Volume

Volume 316,969

May 20, 2022, 3:43 p.m.

Real time quotes

/zigman2/quotes/203149337/composite

Previous close

$ 657.15

$ 657.86

Change

+0.71 +0.11%

Day low

Day high

$647.54

$664.90

Open
Open: 661.29

52 week low

52 week high

$492.13

$747.42

Open

Market cap

$72.19B

Average volume

667,766

P/E ratio

9.22

Rev. per Employee

$1.59M

EPS

70.60

Dividend

N/A

Div yield

N/A

Ex dividend date

N/A

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/regn

MarketWatch News on REGN

  4. Regeneron Pharmaceuticals Inc. stock rises Monday, outperforms market

    5:17 p.m. May 16, 2022

    - MarketWatch Automation

  9. Regeneron Pharmaceuticals Inc. stock falls Monday, underperforms market

    5:18 p.m. May 9, 2022

    - MarketWatch Automation

  13. Regeneron First-Quarter Earnings Top Forecasts

    11:23 a.m. May 4, 2022

    - Barron's Online

  15. Regeneron shares up 1.4% premarket

    6:41 a.m. May 4, 2022

    - Ciara Linnane

  16. Regeneron Q1 EPS $8.61 vs. $10.09 a year ago

    6:37 a.m. May 4, 2022

    - Ciara Linnane

  17. Regeneron Q1 adj. EPS $11.49; FactSet consensus $9.68

    6:37 a.m. May 4, 2022

    - Ciara Linnane

  18. Regeneron Q1 revenue $2.965 bln vs. $2.529 bln a year ago; FactSet consensus $2.690 bln

    6:38 a.m. May 4, 2022

    - Ciara Linnane

  19. Regeneron Pharmaceuticals Inc. stock rises Tuesday, outperforms market

    5:17 p.m. May 3, 2022

    - MarketWatch Automation

  21. Loading more headlines...

Analyst Ratings

/news/nonmarketwatch/company/us/regn

Other News on REGN

  1. Sanofi wins FDA label expansion for Dupixent for new inflammatory condition

    20 min ago

    - Seeking Alpha

  2. Galapagos: Can The Company Turn Around?

    1:18 p.m. May 19, 2022

    - Seeking Alpha

  4. PUTNAM INVESTMENTS LLC Buys 1, Sells 4 in 1st Quarter

    1:00 p.m. May 18, 2022

    - GuruFocus.com

  5. The Correction In Biopharmaceutical Stocks Is Likely Over

    12:51 a.m. May 18, 2022

    - Seeking Alpha

  6. My 'Do Nothing Club' Returned 68% in the Past Year

    9:35 a.m. May 16, 2022

    - GuruFocus.com

  8. Top 5 1st Quarter Trades of Dodge & Cox

    5:00 p.m. May 13, 2022

    - GuruFocus.com

  15. Bayer (BAYRY) Earnings & Revenues Surpass Estimates in Q1

    10:56 a.m. May 10, 2022

    - Zacks.com

  18. Hideout In Healthcare? Here Are Our Top 3 Ideas

    2:07 a.m. May 9, 2022

    - Seeking Alpha

  21. Loading more headlines...
/news/pressrelease/company/us/regn

Press Releases on REGN

  3. Antibody Cocktail Market Key Manufacturers and Industry Demand Analysis to 2030

    3:25 a.m. Today

    - Market Insight Reports

  4. Regeneron Pharmaceuticals REGN Pivots Trading Plans and Risk Controls

    2:52 a.m. Today

    - Stock Traders Daily

  10. When Regeneron Pharmaceuticals (REGN) Moves Investors should Listen

    9:28 a.m. May 10, 2022

    - Stock Traders Daily

  12. Regeneron Announces Investor Conference Presentations

    4:15 p.m. May 2, 2022

    - PR Newswire - PRF

  13. Trend Tracker for Regeneron Pharmaceuticals REGN

    5:23 p.m. April 30, 2022

    - Stock Traders Daily

  18. Regeneron Pharmaceuticals REGN Trading Signals

    12:44 a.m. April 21, 2022

    - Stock Traders Daily

  21. Loading more headlines...

Rates »

Mortgage Equity Savings Auto
Link to MarketWatch's Slice.